Login
$MD
$31.89 +$0.00 (0.0%) After hours

$MD 8-K SEC Filings

Filed On Filing
29 Oct 2026 8-K: Results of Operations and Financial Condition

Executive Vice President, Chief Financial Officer & Treasurer

04 Aug 2026 8-K: Results of Operations and Financial Condition

Executive Vice President, Chief Financial Officer & Treasurer

24 Jul 2026 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure

As previously reported, on May 1, 2026, Pediatrix Medical Group, Inc., a Florida corporation (the “Company”) and Ms. Mary Ann E. Moore determined that Ms. Moore would transition from her role as the Executive Vice President, General Coun...

15 Jul 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

Executive Vice President, Chief Financial Officer & Treasurer

07 May 2026 8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders

As disclosed under Item 5.07 of this Current Report on Form 8-K, at the 2026 Annual Shareholders’ Meeting (the “Annual Meeting”) of Pediatrix Medical Group, Inc., a Florida corporation (the “Company”), held on May 7, 2026, the shareholde...

05 May 2026 8-K: Results of Operations and Financial Condition

Executive Vice President, Chief Financial Officer & Treasurer

19 Feb 2026 8-K: Results of Operations and Financial Condition

Executive Vice President, Chief Financial Officer & Treasurer

03 Nov 2025 8-K: Results of Operations and Financial Condition

Executive Vice President, Chief Financial Officer & Treasurer

18 Aug 2025 8-K: Regulation FD Disclosure; Other Events

Executive Vice President, Chief Financial Officer & Treasurer

05 Aug 2025 8-K: Results of Operations and Financial Condition

Executive Vice President, Chief Financial Officer & Treasurer

01 Jul 2025 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure

Executive Vice President, Chief Financial Officer and Treasurer

08 May 2025 8-K: Submission of Matters to a Vote of Security Holders

On May 8, 2025, Pediatrix Medical Group, Inc., a Florida corporation (the "Company"), held its 2025 Annual Shareholders’ Meeting (the “Annual Meeting”). Of the 85,816,882 shares of common stock outstanding and entitled to vote, 77,889,78...

06 May 2025 8-K: Results of Operations and Financial Condition

Executive Vice President, Chief Financial Officer & Treasurer

18 Apr 2025 8-K: Entry into a Material Definitive Agreement

On April 15, 2025, PMG Services, Inc. (“PMG Services”), a Florida corporation and wholly-owned subsidiary of Pediatrix Medical Group, Inc., and Guidehouse Managed Services LLC, a Delaware limited liability company (“Guidehouse”), agreed ...

20 Feb 2025 8-K: Results of Operations and Financial Condition

FORT LAUDERDALE, Fla., February 20, 2025 - Pediatrix Medical Group, Inc. (NYSE: MD), a leading provider of physician services, today reported earnings of $0.36 per share for the three months ended December 31, 2024. On a non-GAAP basis, ...

14 Jan 2025 8-K: Departure/Election of Directors or Officers; Compensation

Effective on January 12, 2025 (the “Effective Date”), the Board of Directors (the “Board”) of Pediatrix Medical Group, Inc., a Florida corporation (the “Company”), appointed Mr. Mark S. Ordan to serve as the Company’s Chief Executive Off...

13 Jan 2025 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

Executive Chair Mark S. Ordan to Return as Chief Executive Officer

05 Dec 2024 8-K: Departure/Election of Directors or Officers; Compensation

On December 5, 2024, Pediatrix Medical Group, Inc., a Florida corporation (the “Company”), and Dr. Curtis B. Pickert, the current Executive Vice President, Chief Physician Executive and former Chief Operating Officer of the Company, anno...

01 Nov 2024 8-K: Results of Operations and Financial Condition

FORT LAUDERDALE, Fla., November 1, 2024 - Pediatrix Medical Group, Inc. (NYSE: MD), a leading provider of physician services, today reported earnings of $0.23 per share for the three months ended September 30, 2024. On a non-GAAP basis, ...

06 Aug 2024 8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation

FORT LAUDERDALE, Fla., August 6, 2024 - Pediatrix Medical Group, Inc. (NYSE: MD), a leading provider of physician services, today reported a loss of $1.84 per share for the three months ended June 30, 2024. On a non-GAAP basis, Pediatrix...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support